Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biofactors ; 43(1): 73-81, 2017 Jan 02.
Artigo em Inglês | MEDLINE | ID: mdl-27591048

RESUMO

The activity of acetylcholinesterase (AChE) from human erythrocytes was tested in the presence of the phenolic compounds resveratrol and epigallocatechin-3-gallate (EGCG). Even though the stilbene barely changed this enzymatic activity, EGCG did inhibit AChE. Importantly, it preferentially acted on the membrane-bound enzyme rather than on its soluble form. Actually, it was shown that this flavonoid may bind to the red blood cell membrane surface, which may improve the interaction between EGCG and AChE. Therefore, caution should be taken when screening AChE inhibitors. In fact, testing compounds with the soluble form of the enzyme may underestimate the activity of some of these potential inhibitors, hence it would be advisable not to use them as a sole model system for screening. Moreover, erythrocyte AChE is proposed as a good model for these enzymatic assays. © 2016 BioFactors, 43(1):73-81, 2017.


Assuntos
Acetilcolinesterase/metabolismo , Catequina/análogos & derivados , Inibidores da Colinesterase/farmacologia , Membrana Eritrocítica/enzimologia , Estilbenos/farmacologia , Catequina/farmacologia , Avaliação Pré-Clínica de Medicamentos , Membrana Eritrocítica/efeitos dos fármacos , Humanos , Concentração Inibidora 50 , Resveratrol
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA